Zhu et al., 2012 - Google Patents
Transplanting of mesenchymal stem cells may affect proliferation and function of CD4 (+) T cells in experimental autoimmune encephalomyelitisZhu et al., 2012
View PDF- Document ID
- 1189010877424705523
- Author
- Zhu J
- Zhang J
- Li Q
- Du Y
- Qiao B
- Hu X
- Publication year
- Publication venue
- Exp Clin Transplant
External Links
Snippet
Objectives: To research the effects of transplanting mesenchymal stem cells on the development of experimental autoimmune encephalomyelitis and the mechanism behind it. Materials and Methods: An experimental autoimmune encephalomyelitis animal model was …
- 208000000999 Encephalomyelitis, Autoimmune, Experimental 0 title abstract description 89
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Palomares et al. | Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance | |
| Tasso et al. | Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis | |
| Wardell et al. | Harnessing the biology of regulatory T cells to treat disease | |
| Allan et al. | CD4+ T‐regulatory cells: toward therapy for human diseases | |
| Roncarolo et al. | Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications | |
| AU2008313693B2 (en) | Tr1 cells, mesenchymal stem cells and uses thereof | |
| Chen et al. | Lymphocyte-activation gene 3+(LAG3+) forkhead box protein 3−(FOXP3−) regulatory T cells induced by B cells alleviates joint inflammation in collagen-induced arthritis | |
| KR102768442B1 (en) | Novel subsets of CD8+CD45RClow TREGS and their uses | |
| AU2011364392B2 (en) | Method for using regulatory T cells in therapy | |
| Chen et al. | Gene delivery with IFN-γ-expression plasmids enhances the therapeutic effects of MSCs on DSS-induced mouse colitis | |
| Zhu et al. | Transplanting of mesenchymal stem cells may affect proliferation and function of CD4 (+) T cells in experimental autoimmune encephalomyelitis | |
| Jadidi-Niaragh et al. | Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis | |
| Stojanovic et al. | Cell-based tolerogenic therapy, experience from animal models of multiple sclerosis, type 1 diabetes and rheumatoid arthritis | |
| Tian et al. | IL-17 down-regulates the immunosuppressive capacity of olfactory ecto-mesenchymal stem cells in murine collagen-induced arthritis | |
| JP7338903B2 (en) | Purified double-negative T cells and their preparation and application | |
| Keino et al. | Induction of eye-derived tolerance does not depend on naturally occurring CD4+ CD25+ T regulatory cells | |
| AU2020295470B2 (en) | Interleukin-27 producing B-cells and uses thereof | |
| Brate et al. | Therapeutic intervention in relapsing autoimmune demyelinating disease through induction of myelin-specific regulatory CD8 T cell responses | |
| He et al. | Upregulation of CD94 on CD8+ T cells in anterior chamber-associated immune deviation | |
| Guan et al. | Antigen presenting cells treated in vitro by macrophage colony-stimulating factor and autoantigen protect mice from autoimmunity | |
| Kavanagh | Stem Cell and Biological Interventions to treat Allergic Airway Disease | |
| Dahlstrom | Where, when and what do tolerogenic dendritic cells do to T cells? | |
| Fiyouzi Alipour | Identification and characterization of regulatory T cell epitopes | |
| Ghezzi | UNRAVELLING THE ROLE OF MUCOSAL ASSOCIATED INVARIANT T CELLS IN THE PATHOGENESIS OF MULTIPLE SCLEROSIS AND ITS ANIMAL MODEL | |
| Kawai | Modulation of regulatory T cell function through specific molecular pathways in transplantation |